Home

Differential
Counter

Flow
Tutorial

 

  
 
Myeloproliferative
neoplasms		 Neoplasms with eosinophilia
(PDGRA/PDGFRB/FGFR1)		 MDS/MPN MDS AML Acute leukemia
ambiguous lineage
Precursor lymphoid
neoplasms		 Mature B cell
neoplasms		 Mature T and NK
neoplasms		 Hodgkin
lymphoma		 Immunodeficiency associated
lymphoproliferative disorders		 Histiocytic and dendritic
cell neoplasms
 

Nodular Sclerosis Hodgkin Lymphoma
  Unusual antigen expression abstracts Prognostic abstracts Cytogenetic abstracts Antigen chart
Nodular sclerosis classical Hodgkin lymphoma
Mixed cellularity classical Hodgkin lymphoma
Lymphocyte-rich classical Hodgkin lymphoma
Lymphocyte-depleted classical Hodgkin lymphoma
Nodular lymphocyte predominant Hodgkin lymphoma
Article Antigens evaluated
Expression of B-cell markers in classical hodgkin lymphoma: a tissue microarray analysis of 330 cases. CD15, CD20, CD30, CD79a, CD138, EBV-LMP
The B-cell transcription factors BSAP, Oct-2, and BOB.1 and the pan-B-cell markers CD20, CD22, and CD79a are useful in the differential diagnosis of classic Hodgkin lymphoma. BSAP(PAX-5), Oct-2, BOB-1, CD20, CD22, CD79a
T-cell variant of classical Hodgkin's lymphoma with nodal and cutaneous manifestations demonstrated by single-cell polymerase chain reaction. CD15, CD30, Pax-5, TCR beta gene rearrangement
Cytotoxic cell antigen expression in anaplastic large cell lymphomas of T- and null-cell type and Hodgkin's disease: evidence for distinct cellular origin. CD4, CD8, CD56, CD57, Perforin, TIA-1
Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease. CD30, Granzyme B, TIA-1, EBER